Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for Prevention of Atrial Fibrillation After Valvular Surgery
NCT01999829Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeine in Atrial fibrillation (AFib), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Oct 2013; status: completed.
02
Drugs
caffeine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01999829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01999829.